Suppr超能文献

注意缺陷多动障碍筛查工具在寻求物质使用障碍治疗的个体中的应用。

The utility of attention-deficit/hyperactivity disorder screening instruments in individuals seeking treatment for substance use disorders.

机构信息

New York State Psychiatric Institute, Columbia University, College of Physicians and Surgeons, 1051 Riverside Dr, Unit 66, New York, NY 10032, USA.

出版信息

J Clin Psychiatry. 2012 Nov;73(11):e1372-8. doi: 10.4088/JCP.12m07895.

Abstract

OBJECTIVE

Several screening tools for attention-deficit/hyperactivity disorder (ADHD) have been validated in non-substance-abusing populations, but limited data are available regarding their utility in adults with current substance use disorders. The aim of this study was to determine the sensitivity, specificity, and positive and negative predictive values of 3 commonly used ADHD screening instruments in cocaine-dependent individuals.

METHOD

Adults seeking treatment for cocaine dependence (N = 102) were administered 3 self-report instruments between May 2009 and April 2011: the Conners Adult ADHD Rating Scale (CAARS), the Wender Utah Rating Scale (WURS), and the Adult ADHD Self-Report Scale-Version 1.1 (ASRS-V1.1). They then met with master's-level clinicians who administered the Conners Adult ADHD Diagnostic Interview for DSM-IV (CAADID). With the CAADID serving as the gold standard, the validity of the screening instruments was determined, both singly and in combination.

RESULTS

Twenty-five (25%) of the 102 patients met DSM-IV criteria for ADHD or ADHD not otherwise specified (NOS) based on the CAADID. Kappa scores determining agreement between the screening tools and the CAADID (with ADHD NOS labeled as ADHD or labeled as not ADHD) ranged from 0.37 to 0.69. Sensitivity scores for the broadest range of ADHD cases were 80.0%, 87.5%, and 60.9% for the CAARS, WURS, and ASRS-V1.1, respectively. Positive predictive value was highest for the CAARS, at 74.1%, and negative predictive value was highest for the WURS, at 95.1%. The highest sensitivity (96.0%) was found with coadministration of the WURS and CAARS.

CONCLUSION

While all of the screening instruments were found to have adequate sensitivity and specificity, the CAARS outperformed the other instruments in regard to agreement with the CAADID and positive predictive values. However, the WURS, with the highest sensitivity in regard to the broadest range of ADHD cases, may be the single best instrument for preliminary screening purposes. Further, because the ASRS-V1.1 is the simplest and shortest instrument to administer, it may have advantages when a large number of patients need to be screened.

摘要

目的

已有多种注意力缺陷多动障碍(ADHD)筛查工具在非药物滥用人群中得到验证,但有关其在当前物质使用障碍的成年人群中的效用的数据有限。本研究旨在确定 3 种常用于可卡因依赖者的 ADHD 筛查工具的敏感性、特异性、阳性和阴性预测值。

方法

2009 年 5 月至 2011 年 4 月期间,102 名寻求可卡因依赖治疗的成年人接受了 3 种自我报告工具的评估:康纳斯成人 ADHD 评定量表(CAARS)、温德 Utah 评定量表(WURS)和成人 ADHD 自我报告量表第 1.1 版(ASRS-V1.1)。然后,他们与硕士级别的临床医生会面,这些临床医生会进行第四版 DSM 中的康纳斯成人 ADHD 诊断访谈(CAADID)。以 CAADID 作为金标准,确定了筛查工具的单独和联合的有效性。

结果

根据 CAADID,102 名患者中有 25 名(25%)符合 ADHD 或未另作说明的 ADHD(ADHD-NOS)DSM-IV 标准。用于确定筛查工具与 CAADID 之间一致性的 Kappa 评分(将 ADHD-NOS 标记为 ADHD 或标记为非 ADHD)范围为 0.37 至 0.69。CAARS、WURS 和 ASRS-V1.1 用于最广泛的 ADHD 病例的敏感性评分分别为 80.0%、87.5%和 60.9%。CAARS 的阳性预测值最高,为 74.1%,WURS 的阴性预测值最高,为 95.1%。WURS 和 CAARS 联合使用时,敏感性最高,为 96.0%。

结论

虽然所有的筛查工具都具有足够的敏感性和特异性,但 CAARS 在与 CAADID 的一致性和阳性预测值方面优于其他工具。然而,WURS 在最广泛的 ADHD 病例方面具有最高的敏感性,可能是初步筛查的最佳单一工具。此外,由于 ASRS-V1.1 是最简单和最短的管理工具,因此在需要对大量患者进行筛查时,它可能具有优势。

相似文献

2
ADHD Is Highly Prevalent in Patients Seeking Treatment for Cannabis Use Disorders.
J Atten Disord. 2020 Sep;24(11):1487-1492. doi: 10.1177/1087054716640109. Epub 2016 Mar 31.
3
Adult ADHD screening in alcohol-dependent patients using the Wender-Utah Rating Scale and the adult ADHD Self-Report Scale.
J Atten Disord. 2015 Apr;19(4):328-34. doi: 10.1177/1087054714529819. Epub 2014 Apr 17.
4
Screening for adult attention-deficit/hyperactivity disorder in alcohol dependent patients: Underreporting of ADHD symptoms in self-report scales.
Drug Alcohol Depend. 2019 Feb 1;195:52-58. doi: 10.1016/j.drugalcdep.2018.11.020. Epub 2018 Dec 10.
5
Psychopathological rating scales for diagnostic use in adults with attention-deficit/hyperactivity disorder (ADHD).
Eur Arch Psychiatry Clin Neurosci. 2006 Sep;256 Suppl 1:i3-11. doi: 10.1007/s00406-006-1001-7.
7
Screening for attention-deficit/hyperactivity disorder in borderline personality disorder.
J Affect Disord. 2018 Jan 15;226:85-91. doi: 10.1016/j.jad.2017.09.027. Epub 2017 Sep 23.
8
Criterion and concurrent validity of Conners Adult ADHD Diagnostic Interview for DSM-IV (CAADID) Spanish version.
Rev Psiquiatr Salud Ment. 2012 Oct-Dec;5(4):229-35. doi: 10.1016/j.rpsm.2012.05.004. Epub 2012 Jul 4.
10
Criteria and Concurrent Validity of DIVA 2.0: A Semi-Structured Diagnostic Interview for Adult ADHD.
J Atten Disord. 2019 Aug;23(10):1126-1135. doi: 10.1177/1087054716646451. Epub 2016 Apr 28.

引用本文的文献

1
Prevalence of Attention Deficit Hyperactivity Disorder (ADHD) among Substance Use Disorder (SUD) Populations: Meta-Analysis.
Int J Environ Res Public Health. 2023 Jan 10;20(2):1275. doi: 10.3390/ijerph20021275.
3
Adult attention-deficit/hyperactivity disorder symptoms, cognitive dysfunction and quality of life in high-dose use of benzodiazepine and Z-drug.
J Neural Transm (Vienna). 2021 Jul;128(7):1109-1119. doi: 10.1007/s00702-020-02285-w. Epub 2020 Dec 17.
4
Psychometric Properties of a Brief Screening Measure for ADHD in Adults.
Int J Psychol Res (Medellin). 2020 Jul-Dec;13(2):78-88. doi: 10.21500/20112084.4511.
5
Pharmacotherapy of ADHD in Adults With Autism Spectrum Disorder: Effectiveness and Side Effects.
J Atten Disord. 2020 Jan;24(2):215-225. doi: 10.1177/1087054719866255. Epub 2019 Oct 18.
7
Neurocognitive functioning in symptomatic adults with sickle cell disease: A description and comparison with unaffected siblings.
Neuropsychol Rehabil. 2020 Oct;30(9):1666-1681. doi: 10.1080/09602011.2019.1598876. Epub 2019 Mar 29.
10
One-year abstinence improves ADHD symptoms among patients with polysubstance use disorder.
Addict Behav Rep. 2017 Sep 4;6:96-101. doi: 10.1016/j.abrep.2017.08.005. eCollection 2017 Dec.

本文引用的文献

1
Diagnosis of ADHD in adults: what is the appropriate DSM-5 symptom threshold for hyperactivity-impulsivity?
J Atten Disord. 2012 Nov;16(8):631-4. doi: 10.1177/1087054711416910. Epub 2011 Oct 5.
3
The age at onset of attention deficit hyperactivity disorder.
Am J Psychiatry. 2010 Jan;167(1):14-6. doi: 10.1176/appi.ajp.2009.09060796.
8
The prevalence and workplace costs of adult attention deficit hyperactivity disorder in a large manufacturing firm.
Psychol Med. 2009 Jan;39(1):137-47. doi: 10.1017/S0033291708003309. Epub 2008 Apr 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验